Monterey Bio Acquisition Corporation (MTRY)

NASDAQ: MTRY · IEX Real-Time Price · USD
-0.10 (-0.91%)
Jun 5, 2023, 9:30 AM EDT - Market open
Market Cap 52.22M
Revenue (ttm) n/a
Net Income (ttm) -1.07M
Shares Out 4.89M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,201
Open 11.00
Previous Close 11.00
Day's Range 10.89 - 10.90
52-Week Range 9.99 - 11.01
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About MTRY

Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Oct 1, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol MTRY
Full Company Profile

Financial Performance

Financial Statements


Monterey Bio Acquisition Corp. Announces Rebrand and Management Changes

NEW YORK , March 10, 2023 /PRNewswire/ -- Monterey Bio Acquisition Corporation (Nasdaq: MTRYU) today announced a rebrand to Monterey Innovation Acquisition Corp. ("Monterey Innovation" or "the Company...

3 months ago - PRNewsWire

Monterey Bio Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing November 22, 2021

NEW YORK, Nov. 17, 2021 /PRNewswire/ -- Monterey Bio Acquisition Corporation (the "Company") announced today that, commencing November 22, 2021, holders of the units sold in the Company's initial publ...

1 year ago - PRNewsWire

Monterey Bio Acquisition Corporation Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Units

NEW YORK, Oct. 5, 2021 /PRNewswire/ -- Monterey Bio Acquisition Corporation ("Monterey Bio" or the "Company") (Nasdaq: MTRYU) today announced the closing of its previously announced initial public off...

1 year ago - PRNewsWire